Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa

E Rashidghamat, JA McGrath - Intractable & Rare Diseases …, 2017 - jstage.jst.go.jp
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited
blistering diseases that affects~ 500,000 people worldwide. Clinically, individuals with EB …

Innovations in the treatment of dystrophic epidermolysis bullosa (DEB): current landscape and prospects

PC Hou, N Del Agua, SM Lwin, CK Hsu… - … and Clinical Risk …, 2023 - Taylor & Francis
Dystrophic epidermolysis bullosa (DEB) is one of the major types of EB, a rare hereditary
group of trauma-induced blistering skin disorders. DEB is caused by inherited pathogenic …

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa

JY So, J Nazaroff, CV Iwummadu, N Harris… - Orphanet Journal of …, 2022 - Springer
Background Recessive dystrophic epidermolysis bullosa (RDEB) is a rare, devastating
blistering genodermatosis caused by mutations in the COL7A1 gene, which encodes for …

Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa

M Kiuru, M Itoh, MS Cairo, AM Christiano - Dermatologic clinics, 2010 - derm.theclinics.com
The dystrophic forms of epidermolysis bullosa are a group of inherited blistering disorders
caused by mutations in the type VII collagen gene (COL7A1). 1 Recessive dystrophic …

Dystrophic epidermolysis bullosa: pathogenesis and clinical features

L Bruckner-Tuderman - Dermatologic clinics, 2010 - derm.theclinics.com
Dystrophic epidermolysis bullosa (DEB) is an epidermolysis bullosa (EB) subtype with rather
well understood pathogenesis. Its molecular basis—abnormalities of collagen VII—has been …

[PDF][PDF] Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa

WF Yan, DF Murrell - Dermatologic clinics, 2010 - Citeseer
Dystrophic epidermolysis bullosa (DEB) is a severe skin fragility disorder associated with
trauma-induced blistering, progressive soft tissue scarring, and increased risk of skin cancer …

Dystrophic epidermolysis bullosa: a review

S Shinkuma - Clinical, cosmetic and investigational dermatology, 2015 - Taylor & Francis
Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations
in the COL7A1 gene encoding type VII collagen. The deficiency and/or dysfunction of type …

A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa

JY Tang, MP Marinkovich, E Lucas, E Gorell… - Orphanet journal of rare …, 2021 - Springer
Background/objective Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic
collagen disorder characterized by skin fragility leading to blistering, wounds, and scarring …

Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa

J Remington, X Wang, Y Hou, H Zhou, J Burnett… - Molecular Therapy, 2009 - cell.com
Patients with recessive dystrophic epidermolysis bullosa (RDEB) have incurable skin
fragility, blistering, and scarring due to mutations in the gene that encodes for type VII …

[HTML][HTML] EB2017—progress in epidermolysis bullosa research toward treatment and cure

J Uitto, L Bruckner-Tuderman, JA McGrath… - Journal of Investigative …, 2018 - Elsevier
Epidermolysis bullosa, a group of heritable blistering disorders, shows extensive phenotypic
variability due to mutations in as many as 20 distinct genes. There is no cure for this …